This analysis showed that patients with UF expression of the NB-hop biomarker had higher odds of having an age > 18 months, of undergoing an event or relapse/progression, INSS 4 stage tumor, MYCN amplification, p53/RAS gene mutations, or TMM (odd ratio > 1 and p-value < 0.05, Table 7). Here, MYCN is linked to neoplasm.